GNRH-AGONIST CO-TREATMENT DURING CHEMOTHERAPY FOR THE PRESERVATION OF OVARIAN FUNCTION: A META-ANALYSIS.

被引：1
|
作者：
Gharwan, H. [1 ]
Wilkerson, J. [1 ]
Fojo, A. T. [1 ]
机构：
[1] NCI, Bethesda, MD 20892 USA
来源：
FERTILITY AND STERILITY | 2014年 / 102卷 / 03期
关键词：
D O I：
10.1016/j.fertnstert.2014.07.544
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P-59
引用
收藏
页码：E159 / E159
页数：1
相关论文
共 50 条
  • [21] The use of gonadotropin-releasing hormone analog in preservation of ovarian function in women undergoing chemotherapy. A systematic review and meta-analysis.
    Bedaiwy, M. A.
    El-Nashar, S. A.
    Desai, N.
    Hafez, F. F. Abdel
    Abdelkader, A. M.
    Falcone, T.
    FERTILITY AND STERILITY, 2007, 88 : S341 - S341
  • [22] Cotreatment with GnRH-Agonist before and in Parallel to Gonadotoxic Chemotherapy Significantly Preserves Fertility and Increases Pregnancy Rate in Addition to Cyclic Ovarian Function.
    Blumenfeld, Zeev
    Zur, Hilly
    Mischari, Or
    Schultz, Naomi
    Balbir-Gurman, Alexandra
    REPRODUCTIVE SCIENCES, 2014, 21 (03) : 226A - 226A
  • [23] GNRH ANTAGONIST AND LETROZOLE CO-TREATMENT IN NORMAL OVARIAN RESERVE PATIENTS.
    Li, Tingting
    FERTILITY AND STERILITY, 2020, 114 (03) : E334 - E334
  • [24] Assessment of ovarian reserve following ovarian tissue banking and/or GnRH-a co-treatment prior to chemotherapy in patients with Hodgkin’s disease
    Foad Azem
    Nivin Samara
    Tanya Cohen
    Dalit Ben-Yosef
    Beni Almog
    Joseph B. Lessing
    Odeliya Goor
    Ami Amit
    Journal of Assisted Reproduction and Genetics, 2008, 25 : 535 - 538
  • [25] Assessment of ovarian reserve following ovarian tissue banking and/or GnRH-a co-treatment prior to chemotherapy in patients with Hodgkin's disease
    Azem, Foad
    Samara, Nivin
    Cohen, Tanya
    Ben-Yosef, Dalit
    Almog, Beni
    Lessing, Joseph B.
    Goor, Odeliya
    Amit, Ami
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2008, 25 (11-12) : 535 - 538
  • [26] Restart of steroidogenesis in dogs during recrudescence of testicular function following downregulation with a GnRH-agonist implant
    M. Gentil
    B. Hoffmann
    A. Spang
    K. Failing
    S. Goericke-Pesch
    Cell and Tissue Research, 2012, 350 : 513 - 523
  • [27] Management of short stature with GnRH agonist and co-treatment with growth hormone: A controversial issue
    Carel, Jean Claude
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2006, 254 : 226 - 233
  • [28] GnRH agonist versus GnRH antagonist in poor ovarian responders: a meta-analysis
    Franco, J. G., Jr.
    REPRODUCTIVE BIOMEDICINE ONLINE, 2006, 13 (05) : 618 - 627
  • [29] Restart of steroidogenesis in dogs during recrudescence of testicular function following downregulation with a GnRH-agonist implant
    Gentil, M.
    Hoffmann, B.
    Spang, A.
    Failing, K.
    Goericke-Pesch, S.
    CELL AND TISSUE RESEARCH, 2012, 350 (03) : 513 - 523
  • [30] GnRH Analogues as a Co-Treatment to Therapy in Women of Reproductive Age with Cancer and Fertility Preservation
    Valsamakis, Georgios
    Valtetsiotis, Konstantinos
    Charmandari, Evangelia
    Lambrinoudaki, Irene
    Vlahos, Nikolaos F.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (04)
12345